Tellimer

US : Horizon Bancorp, Inc. - HBNC | Maintaining Outperform Rating and Price Target ($21) Following Investor Meetings


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers